Jonathan Javitt

Executive Officer, Director at NRX Pharmaceuticals.

Raised on NRX Pharmaceuticals filings

$3.5M

of $3.5M offered across 1 Form D filing

Form D filings: 1
Teammates: 5
Last filing: Mar 7, 2025

Company

NRX Pharmaceuticals

Biotech · Wilmington, DE

Drugs for suicidal bipolar depression and PTSD

Drugs for suicidal bipolar depression and PTSD

Investors: 2

Investors: 2
Sector: Biotech
HQ: Wilmington, DE

NRX Pharmaceuticals filings

NRX Pharmaceuticals Form D filings
Filed	Security	Sold of offered	Filing
Mar 7, 2025	Option to acquire	$3.5M/ $3.5M	Form D

Option to acquireFiled Mar 7, 2025Form D
$3.5M/ $3.5M

Works with

Also named on NRX Pharmaceuticals filings

Michael AbramsChief Financial Officer, Form D signerForm D signer Michael TaylorDirector Chaim HurvitzDirector Dennis McBrideDirector Patrick FlynnDirector